Yang, Q.-Q.; Guo, J.-A.; Zhang, K.; Li, S.-H.; Xia, W.-Y.; Wang, D.-X.; Xie, L.-S.; Wang, J.-M.; Wu, Q.-F.
Disulfidptosis and Its Hub Gene Slc3a2 Involved in Ulcerative Colitis Pathogenesis, Disease Progression, and Patient Responses to Biologic Therapies. Int. J. Mol. Sci. 2024, 25, 13506.
https://doi.org/10.3390/ijms252413506
AMA Style
Yang Q-Q, Guo J-A, Zhang K, Li S-H, Xia W-Y, Wang D-X, Xie L-S, Wang J-M, Wu Q-F.
Disulfidptosis and Its Hub Gene Slc3a2 Involved in Ulcerative Colitis Pathogenesis, Disease Progression, and Patient Responses to Biologic Therapies. International Journal of Molecular Sciences. 2024; 25(24):13506.
https://doi.org/10.3390/ijms252413506
Chicago/Turabian Style
Yang, Qing-Qing, Jun-An Guo, Ke Zhang, Si-Hui Li, Wan-Yu Xia, De-Xian Wang, Lu-Shuang Xie, Jun-Meng Wang, and Qiao-Feng Wu.
2024. "Disulfidptosis and Its Hub Gene Slc3a2 Involved in Ulcerative Colitis Pathogenesis, Disease Progression, and Patient Responses to Biologic Therapies" International Journal of Molecular Sciences 25, no. 24: 13506.
https://doi.org/10.3390/ijms252413506
APA Style
Yang, Q.-Q., Guo, J.-A., Zhang, K., Li, S.-H., Xia, W.-Y., Wang, D.-X., Xie, L.-S., Wang, J.-M., & Wu, Q.-F.
(2024). Disulfidptosis and Its Hub Gene Slc3a2 Involved in Ulcerative Colitis Pathogenesis, Disease Progression, and Patient Responses to Biologic Therapies. International Journal of Molecular Sciences, 25(24), 13506.
https://doi.org/10.3390/ijms252413506
